Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2022 MedTech R&D Spotlight Call Series

Rhea-AI Summary

Inspire Medical Systems (NYSE: INSP), a leader in medical technology for obstructive sleep apnea (OSA), will participate in the Wells Fargo 2022 MedTech R&D Spotlight Call Series on February 18, 2022, at 10:00 a.m. ET. The presentation will be accessible via a live webcast. Inspire's unique Inspire therapy is the only FDA-approved neurostimulation treatment for moderate to severe OSA, showcasing the company's commitment to innovative solutions. A replay of the presentation will be available for two weeks on Inspire's Investor website.

MINNEAPOLIS, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will be participating in the Wells Fargo 2022 MedTech R&D Spotlight Call Series on February 18, 2022.

Inspire is scheduled to present at 10:00 a.m. Eastern Time. The presentation will be accessible via a live webcast at: https://view.knowledgevision.com/presentation/2c84dae917fb44d88db4a7a37798f38f

A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
bob@lifesciadvisors.com
646-597-6989

FAQ

What is the date of Inspire Medical Systems' presentation at the Wells Fargo 2022 MedTech R&D Spotlight Call Series?

Inspire Medical Systems is scheduled to present on February 18, 2022.

How can I access the live webcast for Inspire Medical Systems' presentation?

The live webcast for Inspire Medical Systems' presentation can be accessed at 10:00 a.m. ET via their official link.

What technology does Inspire Medical Systems specialize in?

Inspire Medical Systems specializes in innovative solutions for obstructive sleep apnea, including their FDA-approved Inspire therapy.

Is there a replay available for Inspire Medical Systems' Wells Fargo presentation?

Yes, a replay of the presentation will be available for two weeks on Inspire's Investor website.

What is the stock symbol for Inspire Medical Systems?

The stock symbol for Inspire Medical Systems is INSP.